InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Kilmal Free
10/27/23 11:02 AM
profile icon
Qcakartracer1 Free
10/18/23 7:58 AM
profile icon
Kilmal Free
06/27/22 8:28 PM
profile icon
Kilmal Free
01/13/20 5:29 PM
profile icon
Stallion4life38 Free
12/18/19 9:56 AM
profile icon
HokieHead Free
12/17/19 1:45 PM
profile icon
Stallion4life38 Free
09/06/19 10:07 AM
profile icon
Welcome2Pinkyland PremiumMember
03/30/19 11:45 AM
profile icon
Welcome2Pinkyland PremiumMember
03/30/19 11:40 AM
profile icon
sweet crude Free
03/19/19 9:55 AM
profile icon
Stallion4life38 Free
03/19/19 12:25 AM
profile icon
sweet crude Free
03/18/19 12:16 PM
profile icon
sweet crude Free
03/18/19 12:07 PM
profile icon
Stallion4life38 Free
03/16/19 3:53 PM
profile icon
Stallion4life38 Free
03/16/19 2:23 PM
profile icon
Stallion4life38 Free
03/15/19 9:43 AM
profile icon
Stallion4life38 Free
03/14/19 4:57 PM
profile icon
Stallion4life38 Free
03/14/19 4:02 PM
profile icon
Stallion4life38 Free
03/14/19 12:36 PM
profile icon
Stallion4life38 Free
03/14/19 12:34 PM
profile icon
Welcome2Pinkyland PremiumMember
03/13/19 11:42 PM
profile icon
Welcome2Pinkyland PremiumMember
03/13/19 11:40 PM
profile icon
mick Grandfathered
02/28/19 4:10 PM
profile icon
Stallion4life38 Free
01/15/19 5:03 PM

Marizyme, Inc. (MRZM) RSS Feed

Followers
7
Posters
36
Posts (Today)
0
Posts (Total)
359
Created
02/17/11
Type
Free
Moderators
GBSX MARIZYME BIOTECH MERGER!




NVSOS NAME CHANGE AND MERGE IN JUST DONE!


https://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=3ZnpU8XWHML%252b4rmlz34uaA%253d%253d&CorpName=MARIZYME%2c+INC

TIMETABLE SUMMARY OF CURRENT AND UPCOMING EVENTS:


CEO Joerg Ott  



Overview: Marizyme is a biotechnology company with clinically tested and patented use of proteolytic enzyme therapy for the treatment of chronic wounds, thrombolysis and dental health.
Krillase® has been classified as a Class III medical device in Europe for treating chronic wounds and application patents have been granted for multiple other areas including thrombosis and dental health.

Patents: Multiple Applications: WO 2008/070698 A1 (June 12, 2008), Also EP2007/086455, US20110135625 Multiple Applications: US 7,947,270 B2 (May 24 2011) Wound Healing: WO 2013/149809 A1 (October 10, 2013) Thrombolysis (Pending): EP 15004350.2 (December 4, 2015) Dental Health: US 12/741,781 (December 30, 2010) Also Published as: WO 2009/060013 A2,A3 and EP 2217266 A2 European Approvals: TUV: Class III Medical Device for Wound Care (July 11, 2005) Filing Contacts: Renata Materna, rmaterna@rmc-rheinfelden.de

http://marizyme.com/about-us/





TINY FLOAT MEANS HUGE ROOM TO RUN HERE TO DOLLARS!
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post